CorMedix (CRMD) EBT (2010 - 2025)

CorMedix has disclosed EBT across 16 years of filings, most recently posting $56.4 million for Q4 2025.

• EBT for Q4 2025 came in at $56.4 million, up 73.52% year-over-year; the trailing twelve-month figure through Dec 2025 was $150.0 million (up 58021.24% YoY), and the FY2025 annual result was $150.0 million, up 58021.24% from the prior year.
• EBT came in at $56.4 million for Q4 2025 at CorMedix, up from $52.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $56.4 million in Q4 2025 to a low of -$15.9 million in Q1 2024.
• The 5-year median for EBT is -$7.5 million (2021), against an average of $2.2 million.
• Across the five-year window, EBT plunged 74.94% in 2023 and soared 1993.4% in 2025, its largest moves.
• CorMedix's EBT stood at -$7.8 million in 2021, then slipped by 5.36% to -$8.2 million in 2022, then slumped by 74.94% to -$14.4 million in 2023, then surged by 326.52% to $32.5 million in 2024, then jumped by 73.52% to $56.4 million in 2025.
• The last three EBT figures came in at $56.4 million (Q4 2025), $52.6 million (Q3 2025), and $20.3 million (Q2 2025), per Business Quant data.